Careium AB (CARE) AI Stock Analysis

• Market Cap: kr480.44M
• Dividend Yield: N/A
• Average Volume (3M): 14.72K
• Price to Earnings (P/E): 16.2
• Beta (1Y): 0.42
• Revenue Growth: 1.30%
• EPS Growth: -2.54%
• Country: SE
• Employees: 548
• Sector: Healthcare
• Sector Strength: 45
• Industry: Security & Protection Services
• EPS (TTM): 0.54
• Shares Outstanding: 24,326,214
• 10 Day Avg. Volume: 10,828
• 30 Day Avg. Volume: 14,717
• PEG Ratio: -0.37
• Price to Book (P/B): 0.85
• Price to Sales (P/S): 0.68
• P/FCF Ratio: 11.29
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 2.01
• Revenue Forecast (FY): kr939.50M

• Rating: 56 Neutral
• Price Target: kr22.00 ▼(-10.57% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back primarily by weak technical conditions (price below key moving averages with negative MACD and very low RSI/Stoch). Financial performance is moderately positive due to the post-2022 turnaround and improved leverage, but softer 2025 margins and uneven free-cash-flow conversion cap the upside. Valuation is reasonable at ~15x earnings, providing some support.

Positive Factors

Profitability recovery

Careium’s shift from loss in 2021–2022 to positive EBIT and net income through 2023–2025, with gross margin near 44% in 2025, indicates structural operational improvements. Sustained profitability enhances reinvestment capacity, reduces funding pressure and supports long-term product development and service scale.

Negative Factors

Margin erosion

The decline in net margin signals rising cost pressure or weaker pricing power, which can materially reduce free cash flow and return on invested capital. Persistently lower margins would constrain the company’s ability to self-fund growth, limit buffer for cyclical downturns and reduce durability of earnings.

Careium AB Business Overview & Revenue Model

Company Description

Careium AB (Publ) provides technology-enabled care services in Sweden, Norway, the United Kingdom, the Netherlands, and the rest of Europe. It offers social alarms and mobile social alarms; smoke, heat, flood, carbon monoxide, and extreme temperat...

Read more

Careium AB (Publ) provides technology-enabled care services in Sweden, Norway, the United Kingdom, the Netherlands, and the rest of Europe. It offers social alarms and mobile social alarms; smoke, heat, flood, carbon monoxide, and extreme temperat...

How the Company Makes Money

Careium AB generates revenue through several key streams, including the sale and subscription of its digital health solutions and monitoring services. The company typically charges healthcare providers, municipalities, and private care organizatio...

Read more

Careium AB generates revenue through several key streams, including the sale and subscription of its digital health solutions and monitoring services. The company typically charges healthcare providers, municipalities, and private care organizatio...

Careium AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	854.10M	870.70M	824.60M	725.10M	587.50M
Gross Profit	375.10M	373.70M	340.50M	273.70M	240.30M
EBITDA	120.60M	150.60M	137.90M	67.90M	65.10M
Net Income	35.80M	58.40M	37.90M	-8.60M	4.70M
Balance Sheet
Total Assets	1.09B	1.05B	961.40M	992.10M	1.05B
Cash, Cash Equivalents and Short-Term Investments	54.90M	31.90M	31.50M	39.90M	142.50M
Total Debt	209.70M	196.80M	225.30M	322.70M	292.30M
Total Liabilities	407.40M	371.40M	361.90M	425.50M	500.20M
Stockholders Equity	681.50M	678.20M	599.50M	566.60M	551.50M
Cash Flow
Free Cash Flow	51.30M	36.90M	61.90M	-87.10M	-70.90M
Operating Cash Flow	143.40M	92.90M	111.90M	-21.10M	-19.80M
Investing Cash Flow	-102.20M	-56.00M	-50.00M	-68.70M	-163.70M
Financing Cash Flow	-13.70M	-39.60M	-69.70M	-15.10M	291.00M

Careium AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 24.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CARE, the sentiment is Negative. The current price of 24.6 is above the 20-day moving average (MA) of 19.93, above the 50-day MA of 21.16, and below the 200-day MA of 24.81, indicating a bearish trend. The MACD of -0.33 indicates Negative momentum. The RSI at 43.58 is Neutral, neither overbought nor oversold. The STOCH value of 39.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CARE.

Careium AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FIRE	76 Outperform	kr1.15B	25.24	―	2.85%	-3.93%	-7.54%
CNCJO.B	75 Outperform	kr542.78M	10.30	4.07%	17.16%	-1.76%	59.61%
CARE	56 Neutral	kr480.44M	16.17	―	―	1.30%	-2.54%
LEVEL	54 Neutral	kr118.97M	-30.10	-1.58%	―	2.70%	85.94%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
IRIS	48 Neutral	kr40.53M	-0.22	-45.32%	―	-41.32%	34.95%
TSEC	41 Neutral	kr107.46M	-38.00	―	―	9.39%	-378.80%